Alibaba Stock Prediction and Forecast [BABA]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 15 Nov 2025, 04:41 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Alibaba Stock Prediction and Forecast [BABA]](https://i.ytimg.com/vi/VfTP8xh6m7I/hqdefault.jpg)
AI-generated source summary
The analysis evaluates Alibaba (BABA) recommending a sell. Score data from November 14, 2025, shows a sell candidate with a score of -2.286, signaling -2.60% loss over 3 days ( -0.87% daily loss). The stock price ended at $153.80 on Friday after losing -3.78%. The three-month trend shows a potential 29.63% change. The 12-month analysis projects a 62.11% increase with a potential range from 38.78% to 109.57%, estimating a future price between $213.45 and $322.31. Analyst ratings are mixed and recent news includes US security concerns and AI developments. The stock has an opening price is undervalued but is still a sell candidate. A sell signal was issued on October 2, 2025, with an 18.77% fall to new bottom pivot. Resistance is at $155.44, support is at $147.10 and volumes increased despite falling prices.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
